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Abstract As the global population grows more of
our fish and seafood are being farmed. Fish are the
main dietary source of the omega-3 (n-3) long-chain
polyunsaturated fatty acids (LC-PUFA), eicosapen-
taenoic (EPA) and docosahexaenoic (DHA) acids, but
these cannot be produced in sufficient quantities as are
now required for human health. Farmed fish have
traditionally been fed a diet consisting of fishmeal and
fish oil, rich in n-3 LC-PUFA. However, the increase
in global aquaculture production has resulted in these
finite and limited marine ingredients being replaced
with sustainable alternatives of terrestrial origin that
are devoid of n-3 LC-PUFA. Consequently, the
nutritional value of the final product has been partially
compromised with EPA and DHA levels both falling.
Recent calls from the salmon industry for new sources
of n-3 LC-PUFA have received significant commer-
cial interest. Thus, this review explores the technolo-
gies being applied to produce de novo n-3 LC-PUFA
sources, namely microalgae and genetically engi-
neered oilseed crops, and how they may be used in
aquafeeds to ensure that farmed fish remain a healthy
component of the human diet.
Keywords Alternative n-3 LC-PUFA sources 
Aquaculture  EPA and DHA  Farmed Fish  Human
health  Oils from transgenic plants  Polyunsaturated
fatty acids
Introduction
The continual increase in the global population
presents a significant challenge to food security,
particularly with respect to providing an adequate
supply of nutritious, safe and affordable high quality
food. Seafood is a rich source of protein, vitamins and
minerals as well as being the main dietary source of
the omega-3 (n-3) long-chain polyunsaturated fatty
acids (LC-PUFA), eicosapentaenoic (EPA; 20:5n-3)
and docosahexaenoic (DHA; 22:6n-3) acids, that are
conditionally essential for human health and develop-
ment (Calder 2014; Tocher 2015). Indeed, consuming
at least two portions of fish per week, of which one
should be oily, is advised by global health authorities
as a means of achieving a recommended daily intake
of 250–1000 mg EPA ? DHA in order to protect
against cardiovascular and inflammatory diseases
among other health benefits (SACN/COT 2004;
GOED 2014). Nevertheless, the capacity of wild
capture fisheries to satisfy the increased demand for
seafood is limited and unsustainable.
Aquaculture, the farming of aquatic organisms, is
currently the fastest growing animal protein-food
producing sector supplying over 50% of the world’s
fish and seafood for human consumption (FAO 2016).
However, aquafeeds have traditionally relied upon the
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inclusion of marine ingredients, fishmeal and fish oil,
themselves sourced from wild fisheries to supply
essential nutrients as well as the high EPA and DHA
levels typically associated with farmed carnivorous
marine fish species such as Atlantic salmon (Salmo
salar). As the industry has grown to meet consumer
demands, these finite marine ingredients have gradu-
ally been replaced in aquafeeds with alternatives,
primarily of terrestrial agricultural origin. Marine
ingredients in Norwegian salmon feeds, for instance,
decreased from 90% to around 30% inclusion between
1990 and 2013 (Ytrestøyl et al. 2015). The replace-
ment of the marine protein source, fishmeal, has
generally been accomplished through the use of plant-
based protein sources such as soy products, although
these can possess negative traits such as amino acid
imbalances or the presence of anti-nutritional factors,
and are also susceptible to fluctuations in price (Gatlin
et al. 2007). Nonetheless, reducing the reliance on
marine protein sources differs greatly from that of
reducing marine oil use.
Fish and plant oils both contain n-3 polyunsaturated
fatty acids (PUFA) but terrestrial plants only contain
the shorter-chain type such as a-linolenic acid (ALA;
18:3n-3) and are completely devoid of any EPA and
DHA. As with humans, coldwater marine finfish are
inefficient at convertingALA, themetabolic precursor,
into appreciable levels of the beneficial EPA and DHA
and, therefore, these must be supplied in the diet
(Tocher 2015).Thus, the increasing use of vegetable oil
as a replacement for fish oil in aquafeeds has subse-
quently resulted in the decline of the beneficial n-3 LC-
PUFA in farmed fish, particularly salmon, thereby
reducing the nutritional value to the final consumer and
questioning the current dietary guidelines with respect
to fish intake (de Roos et al. 2017; Sprague et al. 2016).
With gaps in the actual versus recommended intake of
EPA and DHA for the majority of the world’s
population (Stark et al. 2016), and also in the supply
and demand for n-3 LC-PUFA (Naylor et al. 2009;
Tocher 2015), there is therefore a pressing need for
novel de novo sources of n-3 LC-PUFA. Indeed, the
Global Salmon Initiative has invited commercial
organisations to supply its members with up to
200,000 tons annually of novel omega-3 rich oils to
support the sustainable use of marine oils in aquafeeds
(GSI 2015). This review explores the recent commer-
cial interest by both agri-biotechnology and bioengi-
neering companies and considers the main options that
are likely to complement fish oil use as future sources
of EPA and DHA in aquafeeds.
Other marine sources
As n-3 LC-PUFA are largely derived from the marine
environment it would therefore appear logical that the
focus on alternative sources begins there. Both com-
mercial and scientific interests have centred on lower
trophic organisms with potential candidates such as
Antarctic krill (Euphasia superba) and calanoid cope-
pods (Calanus finmarchicus) already investigated as
sources of n-3 LC-PUFA for use in salmonid feeds
(Olsen et al. 2004, 2006). Although several species of
krill have been fished, the main current large-scale
fisheries are of Antarctic krill from the Southern Ocean
as well as Pacific krill (Euphasia pacifica) off the
coasts of Japan and Canada (Olsen et al. 2011). The
primary commercial drivers for the current krill fishery
are nutritional supplements for direct human consump-
tion due to krill oil having a uniquely high content of
phospholipid-bound n-3 LC-PUFA, which are thought
to be more bioavailable, as well as being involved in
regulating more metabolic pathways than the triacyl-
glycerol-bound EPA and DHA found in fish oils
(Ulven andHolven 2015). The by-product, krill meal is
currently used in small amounts as a speciality
ingredient in niche aquaculture feeds, primarily based
on beneficial palatability/feed attractant, antioxidant
and immune enhancing properties (Katevas 2014).
Copepods accumulate high levels of lipids of up to
50–70% of body dry weight that are of interest to
aquaculture (Falk-Petersen et al. 2009), although only
small-exploratory-scale harvesting of Calanus has
occurred to date (Olsen et al. 2011). Nevertheless,
C-Feed AS (Trondheim, Norway) currently grow
copepods on a commercial scale as live feeds for early
developmental stages of marine fish, crustaceans and
other marine organisms (C-Feed 2014). In addition to
the above, there is also a growing interest in using
underutilized sources such as fishery and aquaculture
by-products and mesopelagic fish among other marine
sources (Olsen et al. 2011). However, production
volumes from all these sources are relatively low and,
although apparently sustainably managed, concerns
have been raised regarding the potential effects that
harvesting down the trophic chain may have on higher
trophic species that rely upon this food source (Hill
et al. 2006).
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Microalgae and microbial sources
Microalgae, along with other single cell microbes, are
the primary producers of n-3 LC-PUFA in the aquatic
environment, providing a continual supply of EPA and
DHA that is concentrated through the trophic food
chain where there is limited capacity to synthesize
these beneficial fatty acids. Accordingly, microbial
sources offer a natural way of increasing the supply of
n-3 LC-PUFA for farmed fish and have already been
used by the aquaculture industry to enrich live feeds,
rotifers and Artemia, in these fatty acids prior to
feeding to larval fish (Barclay and Zeller 1996;
Benemann 1992; Nichols et al. 1996; Lewis et al.
1998) as well as directly in formulated feeds for larval
and juvenile fish (Eryalc¸in et al. 2013; Ganuza et al.
2008; Norambuena et al. 2015; Sarker et al. 2016).
However, it is at later life stages (grow-out), where
microalgae are not the natural food source and greater
volumes of product are required, that microbial
biotechnology can potentially deliver an alternative
and promising approach to the traditional marine-
derived ingredients for aquafeeds.
Several factors need to be taken into consideration
when screening potential microbial sources for mass
culture. Species and strain are both important with ideal
candidates possessing key desirable characteristics
such including a high n-3 LC-PUFA and oil contents,
fast growth rate and the capacity for large-scale cost-
effective production. Species that have high levels of
EPA orDHAbut lack the high lipid content required for
enriching flesh of farmed fish for human nutrition may
be suitable as alternative protein sources in aquafeeds.
Phaeodactylum tricornutum, Nannochloropsis sp. and
Desmodesmus sp. for example, have all been investi-
gated as fishmeal replacements in salmon feeds with
varying results (Gong et al. 2017; Sørensen et al. 2016),
and may one day offer the possibility for the complete
replacement of fishmeal and fish oil in aquafeeds as
their n-3 LC-PUFA content could at least meet the
essential fatty acid (EFA) requirements of the fish being
farmed. Complete replacement of both fishmeal and
fish oil has already been achieved using microalgae in
juvenile Nile tilapia, Oreochromis niloticus (Sarker
et al. 2016). Similarly, other microbial species may
provide other benefits as feed additives in aquafeeds
such as the freshwater green microalgae, Haematocco-
cus pluvialis, in replacing synthetic carotenoids in
salmon feeds (Benemann 1992; Panis and Rosales
Carreon 2016), although products originating from
bacteria, derived from Paracoccus carotinfaciens and
marketed as Panaferd-AX (Nippon Oil Corporation,
Japan), and yeast, derived from Phaffia rhodozyma, are
already used by the salmon industry. In addition to
species, culture conditions (e.g. light, temperature,
nutrient source) can also affect algal composition,
including fatty acid profile, thereby complicating the
ability to produce a product of consistent quality and/or
in sufficient quantity (Glaude and Maxey 1994; Jiang
et al. 1999; Hamilton et al. 2015). Due to these issues,
culture of photoautotrophic microalgae in outdoor
ponds or photobioreactors is currently insufficient to
produce the high n-3 LC-PUFA biomasses required by
global aquaculture. In contrast to photoautotrophic
systems, heterotrophic production via fermentation,
which utilizes sugars and other carbon sources for
energy, may take only a few days and can therefore be
tailored to meet market requirements.
The main driver for using heterotrophic microalgae
as a source of n-3 LC-PUFA in aquaculture has arisen
largely from the progression made in the more
lucrative nutraceutical market, specifically the infant
formula sector, which has the largest global market
share for packaged EPA/DHA products other than fish
(Packaged Facts 2012). Microbial species such as the
marine diatom, Crypthecodinium, as well as the
thraustochytrids, Thraustochytrium,Ulkenia, but espe-
cially Schizochytrium sp., have been identified due to
their ease of cultivation under controlled conditions to
produce high lipid biomasses rich in n-3 LC-PUFA and
with high n-3:n-6 PUFA ratios (Lewis et al. 1999;
Nichols et al. 2004; Ratledge 2005). However, one
feature of Schizochytrium sp., and of thraustochytrids
in general, is that they also produce significant amounts
of n-6 docosapentaenoic acid (DPA; 22:5n-6), usually
at a level of around 20% of the level of DHA produced,
and this may increase the levels of n-6 DPA in the flesh
of fish fed algal biomass (Kousoulaki et al. 2015, 2016;
Sprague et al. 2015). However, n-6 DPA is considered
a metabolically neutral fatty acid that has no overall
impact onDHAuptake in humans (Nauroth et al. 2010;
Ratledge 2005). Furthermore, the biomass grown
under controlled heterotrophic fermentation is gener-
ally free from contaminants such as heavy metals,
dioxins and polychlorinated biphenyls (Ratledge
2005), resulting in lower levels of these undesirables
in both the feed and fillet flesh than in fish fed a standard
marine fish oil diet (Sprague et al. 2015).
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Miller et al. (2007) demonstrated that oil extracted
from Schizochytrium biomass can be used at high
inclusion levels to replace fish oil in the diets of salmon
parr with no detriment to growth while also increasing
fleshDHA levels. However, amajor limitation to using
algal oil in aquafeeds is that it can be expensive to
extract from the biomass, compared to current fish oil
prices. Once extracted, there are also additional
difficulties related to protecting the LC-PUFA from
oxidation as the natural antioxidants within the
microalgae are no longer effective once the cell is
ruptured during the extraction process (Miller et al.
2007; Winwood 2013). Carrier oils containing antiox-
idants, such as high oleic sunflower oil, may be used to
stabilize the refined oil (Gray 2010). However, due to
these issues, most commonly it has been the lipid-rich
(generally *40–60%) whole cell algal biomass that
has been used directly in aquafeeds, although this itself
can present problems particularly during the extrusion
process when manufacturing the feeds. Carter et al.
(2003), for example, replaced fish oil with a thraus-
tochytrid biomass in juvenile salmon during the
seawater transfer phase and found no difference in
growth performance, although fish fed fish oil-based
diets performed better under challenging conditions
when presented with a Vibrio anguillarum bacterium.
In a 12-week study in which post-smolts were grown
from *200 to 800 g and fed graded levels of
Schizochytrium sp. biomass replacing fish oil, Kou-
soulaki et al. (2015) found that fish fed all inclusion
levels performed well in terms of growth, health and
fillet quality, including DHA retention particularly at
6% compared to 15% inclusion. In a similar study,
Sprague et al. (2015) used a commercially available
drum-dried Schizochytrium sp. biomass (DHAgold,
formerly AquaGrow Gold; DSMNutritional Products,
Parsippany, NJ, USA) at 5.5 and 11% inclusion to
replace fish oil in post-smolt salmon grown from 1500
to*3000 g. Although salmon fed the 11% Schizochy-
trium biomass exhibited a minor, but significant, lower
growth rate than fish fed a fish oil diet, fleshDHA levels
were similar and higher than fish fed 5.5% algal
biomass. Caution should always be applied when
comparing studies, not only due to the different fish
sizes/life-stages used in experiments, but also due to
differences in the composition of control/reference
diets used. For example, the reference diets used by
Sprague et al. (2015) contained 27% fish oil as the sole
dietary oil source, whereas, in the studies of
Kousoulaki et al. (2015) and Carter et al. (2003),
reference diets contained fish oil levels of 15 and 9.1%,
respectively, in combination with vegetable oils.
Commercial salmon feeds currently generally
incorporate blends of vegetable and fish oils to meet
the nutritional demands of the fish being farmed,
although compositions are continually evolving due to
the pressures on marine sources, thereby altering n-3
LC-PUFA fillet levels (Ytrestøyl et al. 2015; Sprague
et al. 2016). Thus, the fish farming industry must
decide whether future sources are required simply to
maintain EPA and DHA at current levels, where diets
are mainly of vegetable origin with relatively low n-3
LC-PUFA contents, or whether the aim is to return to
the historical levels obtained when diets contained
high levels of fishmeal and fish oil and thus, much
higher EPA and DHA contents. However, it is likely
that both production volumes and the economics of
microalgae production will ultimately be the deter-
mining factor in this choice. Nevertheless, Schizochy-
trium still offers potential as an alternative to fish oil,
not only for salmon, but also for other commercially
important species such as gilthead sea bream, Sparus
aurata (Ganuza et al. 2008), channel catfish Ictalurus
punctatus (Li et al. 2009), Nile tilapia (Sarker et al.
2016) and Pacific white shrimp, Litopenaeus van-
namei (Wang et al. 2017) in which Schizochytrium
products have been investigated.
Within the last year several algae-based and animal
nutrition companies have announced novel product
lines specifically aimed for use in aquaculture as
sustainable alternatives to fish oil. This was largely
stimulated by the Global Salmon Initiative’s call
towards the end of 2015 for organizations to develop
and produce 25,000 to 200,000 tons annually of novel
oils with levels of n-3 LC-PUFA sufficient to support
fish farming (GSI 2015). Archer Daniels Midland
(ADM) Animal Nutrition (Quincy, IL, USA) for
example, released a dried algae biomass, ‘DHA
Natur’, with a DHA content of 17–20% as-is (ADM
2017). Alltech (Winchester, KY, USA) released their
product, ‘ForPlus’, which may have been validated in
salmon (Kousoulaki et al. 2015, 2016). The microalgal
product has also been incorporated into their Coppens
International, ‘NeoGreen’ fishmeal- and fish oil-free
range of trout diets (Tsappis 2017). Meanwhile,
TerraVia Holdings Inc. (formerly Solazyme; San
Francisco, CA, USA) and Bunge Ltd. (White Plains,
NY, USA) have jointly developed a whole algae
1602 Biotechnol Lett (2017) 39:1599–1609
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biomass from Schizochytrium called ‘AlgaPrime
DHA’ with a DHA content of C28% as-is, which is
fermented using a sugarcane feedstock at a new
production facility in Brazil (TerraVia Holdings, Inc.
2016). Moreover, the companies have an agreement to
supply this product to the BioMar Group (Aarhus,
Denmark), one of the three main global fish feed
companies (Bunge 2017). These developments are a
step in the right direction in terms of reversing the
decline in n-3 LC-PUFA contents of farmed fish,
especially salmon (Sprague et al. 2016).
All the above algal products, however, only provide
one of the two beneficial n-3 LC-PUFA, DHA, and do
not supply EPA. For example, Sprague et al. (2015)
found that while no difference in DHA content was
observed between salmon fed diets containing Schizo-
chytium biomass and fish oil, the overall nutritional
value to the human consumer, in terms ofEPA ? DHA,
was lower due to the near absence of EPA in the algal
feed. The fatty acids EPA and DHA exert a range of
biological activities in humans, some overlapping but
others distinct for each fatty acid (Calder 2014). Fish oil,
therefore, remains the main source of marine-derived
EPA at present, as EPA-producing algal sources have
largely been of photosynthetic origin although attempts
have been made to culture some species heterotrophi-
cally and optimize conditions to enhance biomass and
lipid contents (Marudhupandi et al. 2016; Ratledge
2005). Nevertheless, a Schizochytrium strain/species
with a minimum EPA and DHA content of 10 and 22%
of total fatty acids, respectively,was reportedpreviously
(Gray2010). Furthermore,DSM(Heerlen,Netherlands)
and Evonik Industries AG (Essen, Germany) have
recently formed a joint venture,Veramaris, coupling the
former’s unique knowledge in cultivating marine
organisms, especially Schizochytrium, with the latter’s
expertise in developing industrial fermentation biotech-
nology, to produce an EPA ? DHA-rich Schizochy-
trium algal oil for the animal feed industry. Full-scale
production is anticipated in 2019 and will be situated in
theUSA,where the carbon sourcewill be dextrose (corn
syrup) obtained from local corn/maize production. The
resultant extracted algal oil is expected to provide 15%
of the total current annual demand by the salmon
farming industry for EPA and DHA (DSM 2017). As
previously mentioned, manufacturing a highly-concen-
trated oil from algal biomass has additional technical
difficulties such as optimization of fermentation condi-
tions to maximize n-3 LC-PUFA yield and upscaling to
commercial production. An alternative approach may
therefore be to genetically engineer microalgae to
specifically optimize the production of the desired fatty
acids, EPA and DHA.
Transgenic sources
Although research has been undertaken to genetically
modify microbes, including microalgae, in an attempt
to produce or optimize n-3 LC-PUFA content (Hamil-
ton et al. 2014, 2015), the main focus for bioengi-
neering novel EPA- and/or DHA-rich oils as
alternatives to fish oil has centred on oilseed crops.
Terrestrial plants do not produce n-3 LC-PUFA
because they lack the necessary genes (enzymes)
required to elongate and desaturate shorter chain
PUFA, namely ALA (18:3n-3), that can be abundant
in some oilseed plants and, therefore, selective breed-
ing cannot be used to develop new agricultural crop-
based sources of EPA and DHA, making genetic
modification (GM) the only option.
The biosynthesis of LC-PUFA in marine microal-
gae generally occurs through a series of aerobic
elongation and desaturation reactions. The more
common pathway involving a D6 desaturation of
ALA followed by elongation to 20:4n-3 and then
further desaturation by a D5 desaturase to produce
EPA. Alternatively, ALA can be elongated to 20:3n-3
before undergoing sequential D8- and D5-desatura-
tions to form EPA. DHA may then be synthesized by
further elongation together with D4 desaturation
(Harwood and Gushina 2009; Napier et al. 2015;
Ruiz-Lopez et al. 2015). The genes involved in these
pathways have all been identified and characterized in
several microalgal species enabling their introduction
into terrestrial oilseed plant hosts.
The two oilseed crops that have been viewed as
potential platforms for engineering n-3 LC-PUFA are
Camelina (Camelina sativa) and Canola (Brassica
napus L.) with research primarily being led by the
Agricultural Science Research Institute, Rothamsted
Research (Harpenden, UK) and the Australian
National Science Agency, the Commonwealth Scien-
tific and Industrial Research Organisation (CSIRO,
Australia). The successful accumulation of n-3 LC-
PUFA into plant hosts has been primarily based upon
work performed in the model species Arabidopsis
(Petrie et al. 2012; Ruiz-Lopez et al. 2013). Ruiz-
Lopez et al. (2014) then transferred this technology to
Biotechnol Lett (2017) 39:1599–1609 1603
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Camelina as a host species with constructs consisting
of five or seven marine microalgal genes for the
purpose of engineering an EPA-only or an
EPA ? DHA oil, respectively. The authors reported
an EPA content of 24% of total fatty acids in the EPA-
only oil, whereas the EPA ? DHA iteration gave an
EPA and DHA content of 11 and 8% respectively. The
levels of the substrate for EPA synthesis, ALA, and
oleic acid (18:1n-9) were reduced in the transgenic
plants. These n-3 LC-PUFA levels have also been
replicated outside laboratory conditions when grown
in the field, representing a viable alternative to fish oil
use in aquafeeds (Usher et al. 2015). Similarly, using
different constructs, Petrie et al. (2014) demonstrated
significant levels of DHA production, of up to 12.4%
of total fatty acids, in oil from transgenic Camelina,
although EPA content was relatively low (0.8–3.3%)
in comparison to that obtained by Ruiz-Lopez et al.
(2014).
An alternative anaerobic pathway that can produce
LC-PUFA, favoured by some bacteria and a few
marine eukaryotes, involves polyketide synthase that
can directly biosynthesize unsaturated fatty acids,
including n-3 LC-PUFA, from C2 units supplied by
malonyl-CoA without the need for additional desat-
urases (Harwood and Gushina 2009; Napier et al.
2015). Walsh et al. (2016) used this pathway to
engineer Canola to produce an oil with EPA and DHA
content of 0.7 and 3.7% of total fatty acids, respec-
tively, equivalent to 600 mg in a 14 g serving. The
same authors reported that by engineering the same
PUFA synthase system in soybean, an oil containing
2.7% DHA and 1.5% EPA was achieved. While the
levels of EPA and DHA produced using the polyketide
approach were much lower than those demonstrated
using the aerobic microalgal elongase/desaturase
genes (Petrie et al. 2014; Ruiz-Lopez et al. 2014), it
still represents a further option for the production of
novel oils containing n-3 LC-PUFA.
To date, the only studies reporting the use of oils
from n-3 LC-PUFA GM crops as ingredients in fish
feeds have been those using oils from transgenic
Camelina produced by Rothamsted Research. In the
first of a series of trials, Betancor et al. (2015a, b) used
the EPA-rich oil described by Ruiz-Lopez et al. (2014)
in feeds for post-smolt salmon grown in seawater from
*80 to 200 g. No differences in growth performance,
feed efficiency or survival were observed between
dietary treatments. Furthermore, flesh of fish fed a diet
containing the EPA-rich Camelina oil contained
higher EPA levels than fish fed diets containing either
the wild-type Camelina oil or fish oil while, as
expected, flesh DHA levels were lower in fish fed
both the transgenic and wild-type Camelina oil-based
diets compared to fish fed the fish oil diet. In contrast,
liver fatty acid profiles of fish fed the diet containing
oil from transgenic Camelina showed higher levels of
DHA and DPA (22:5n-3) as well as EPA compared to
fish fed wild-type Camelina, indicating active biosyn-
thesis of DHA from EPA, which was consistent with
increased expression of hepatic desaturase (fads2d6
and fads2d5) and elongase (elovl2) genes in the fish
fed the oil from GM Camelina.
In a subsequent study, also in salmon, Betancor et al.
(2016a) investigated an oil containing around 6% each
of EPA andDHA, obtained from a subsequent iteration
of transgenic Camelina. Again, no differences in
growth or health parameters were observed over the
12-week feeding trial, with fish growing from*250 to
*540 g. Fish fed diet containing oil from transgenic
Camelina demonstrated enhanced digestibility of EPA
and DHA as well as higher levels of n-3 LC-PUFA in
all tissues compared to fish fed a diet containing oil
from wild-type Camelina. Furthermore, absolute
amounts of n-3LC-PUFA infish fed the diet containing
oil from transgenic Camelina were similar to those fed
a diet containing fish oil. These initial studies utilized
reference diets (termed fish oil diets above) that
contained relatively high levels of fishmeal and fish
oil, which represented ‘‘gold standard’’ feeds contain-
ing high levels of n-3 LC-PUFA. In a follow-up study,
the EPA ? DHA oil from transgenic Camelina was
again investigated in salmon, but compared to a
reference diet that reflected current commercial
salmon feed formulations, with higher levels of plant
meals and vegetable oil and lower levels of fishmeal
and fish oil (Betancor et al. 2017). Following a 12-week
feeding period, from an initial weight of*120 g to a
final weight of *400 g, no significant differences
between treatments were found in growth or health
parameters. Moreover, fish fed the oil from transgenic
Camelina contained almost double the n-3 LC-PUFA
content than fish fed either the fish oil or wild-type
Camelina oil feeds, thereby demonstrating the poten-
tial of the oils fromGMcrops to increase n-3LC-PUFA
levels in salmon. Further steps in the commercialisa-
tion will allow for the testing of these important n-3
LC-PUFA sources in harvest-sized salmon.
1604 Biotechnol Lett (2017) 39:1599–1609
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In addition to salmon, theEPA-only andEPA ? DHA
oils from transgenic Camelina have also been tested in
another commercially important farmed marine species,
gilthead sea bream (Betancor et al. 2016b). As in salmon,
theGM-derived oilswere found to be suitable alternatives
to fish oil in sea bream diets. However, fish fed the EPA-
only oil showed slightly reduced growth performance
when compared to fish fed both the fish oil reference diet
the and EPA ? DHACamelina oil, but similar growth to
fish fed the wild-type Camelina oil. Although no obvious
alteration in fish health was found in either histological or
molecular observations the reduced growth in the EPA-
only dietwas suggested to be related to a dietary inbalance
in fatty acid ratios, i.e. EPA/DHA or n-3/n-6, or specific
fatty acids such as 20:4n-6. This additional study in sea
bream,alongwith another study thatdemonstrated that the
EPA-only oil was an effective source of bioavailable EPA
in mice (Tejera et al. 2016), were further validations
supporting the potential for commercialisation of these
GM Camelina-derived oils, particularly as ingredients in
feeds for farmed fish.
Production of the oils fromGMoilseed crops should
be straight forward as cultivation of the crops presents
no specific agronomic difficulties and the processing
technology and infrastructure is already in place for the
extraction of oil from seed crops. The main issue in
terms of potential production will simply be the
volumes of oils produced using such technology.
Napier et al. (2015) estimated that 200,000 ha of
transgenic Camelina, less than 3% of the arable land
(*7 million ha) presently used by Canada to grow
oilseed crops, could theoretically produce 150,000
tonnes of oil equivalent to around 15% of the global
harvest of marine oils.
At present, no commercial production of novel n-3
LC-PUFA oils, as defined as containing EPA and/or
DHA, from GM oilseed crops has been reported.
However,DuPont (Wilmington,DE,USA) developed a
transgenic oleaginous yeast, Yarrowia lipolytica, to
produce a high level EPA biomass through industrial-
scale fermentation (Xi et al. 2015). The DuPont
transgenic yeast biomass was used by AquaChile
(Puerto Montt, Chile) to produce a niche product,
Verlasso salmon, but recently the yeast biomass has
apparently been replaced with a microalgal product,
presumably aDHA-rich algal biomass (Verlasso 2017).
The reason for this change is unclear, but it may be
related to the fact that DHA has higher retention in
salmon compared to EPA retention, which can be
highly variable and even result in a net loss of EPA,
especially when dietary DHA levels are low (Glencross
et al. 2014).
Similarly, the Monsanto company (St Louis, MO,
USA) has produced a GM soybean line that produces
an oil containing stearidonic acid (SDA; 18:4n-3), a
fatty acid that is more readily converted to EPA in
humans than the ALA found in conventional plant
sources (Harris et al. 2008). When fed to Atlantic
salmon, SDA-rich oils, including the GM-soy oil,
failed to elicit an increase in fillet EPA or DHA levels,
although SDA was elongated to 20:4n-3 that, nonethe-
less, may be more easily converted to EPA in the
human consumer compared to ALA found in the flesh
of fish fed current formulations including high levels
of rapeseed oil (Bell et al. 2006; Nanton et al. 2012;
Tocher et al. 2006). Nevertheless, with the rapid
development of novel EPA andDHA oils, it is unlikely
that the GM-SDA-soy oil will be used to any large
extent in aquafeeds, despite its approval for use in
animal feeds in Europe (EFSA 2014), but may be
included in foodstuffs for direct human consumption.
It would therefore appear that the preferred new n-3
LC-PUFA sources, from both fish farming industry
and human nutrition perspectives, will be oils that are
rich in either DHA or, ideally, both EPA and DHA.
Collaboration between CSIRO, Nuseed (Nufarm
Ltd., Melbourne, Australia) and the Australian Grains
Research and Development Corporation (GRDC) has
resulted in a DHA-rich Canola which, when grown, has
the potential to produce a similar n-3 LC-PUFAyield to
approximately 10,000 kg fish from just one hectare
(Nuseed 2017). Company information suggests that the
transgenic oil will be marketed for both use in aquafeed
(Aquaterra) and human nutrition (Nutriterra) and,
providing all the regulatory requirements are met,
commercial production is expected to commence in
Australia, Canada and the United States in either 2018
or 2019 (Nuseed 2017). Dow AgroSciences (Indi-
anapolis, IN, USA) in association with DSM have
developed both a soybean product containing 1.5 and
2.7%EPAandDHA, respectively, aswell as theCanola
oil containing 0.7% EPA and 3.7% DHA described by
Walsh et al. (2016). Although the Canola oil has been
field tested there is currently no information available as
to when either product will be commercialized.
Another key player, the chemical company BASF
SE (Ludwigshafen, Germany) and Cargill Inc. (Min-
nesota, MN, USA), the global food and agricultural
Biotechnol Lett (2017) 39:1599–1609 1605
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company that also owns the fish feed producer Ewos,
have partnered to develop a GM Canola producing a
high n-3 LC-PUFA oil for use in aquafeeds by 2020
(Cargill 2016). No further information on the trans-
genic oil per se is available, but the biosynthetic
pathway consisting of ten enzymes, used to engineer
EPA and DHA in the transgenic Canola, has been
demonstrated (Yilmaz et al. 2017). Calysta Inc.
(Menlo Park, CA, USA) in partnership with CHAIN
Biotech Ltd. (London, UK) are developing a GM
Methanococcus microbe capable of converting
methane gas into n-3 LC-PUFA during fermentation
(Calysta 2016). The finished product is most likely to
be high in protein and may feature as a fish meal
replacement with the added benefit of being enriched
in n-3 LC- PUFA.
While many of these GM products have been under
development for many years, the Global Salmon
Initiative’s call for novel oils high in n-3 LC-PUFA for
fish feeds has more than likely accelerated their recent
marketing. Nevertheless, Europe has a rigorous reg-
ulatory framework when it comes to GM crop
cultivation. Indeed, some of the companies looking
to grow transgenic n-3 LC-PUFA crops are focussing
outside Europe in places such as the US or Canada
where GM crop authorisation can be granted more
quickly, often by up to 15–20 months as compared to
Europe (Lucht 2015).
Perhaps the greatest challenge in getting GM
products to market, including animal feed, is con-
sumer acceptance, particularly in some European
countries. It is thought that around 90% of soybeans
traded globally contain GM material and, as such, a
large proportion of animal feed available in the EU
already contains GM components (Lucht 2015; Van
Eenennaam and Young 2014). The EU’s GM Food
and Feed Regulation (EC) No. 1829/2003 currently
states that products derived from an animal reared on
feeds containing GM ingredients do not need to be
labelled as such. Therefore, while oils from transgenic
plants would have to be labelled as GM if sold directly
to humans, salmon reared on feeds containing the oils
would not. Informing and educating the public could
potentially increase acceptance. For example, those
that feel more informed about science and GM foods,
particularly when the potential benefits are pointed out
such as increased omega-3 content or sustainability,
are more likely to support GM foods (Desaint and
Varbanova 2013; Lucht 2015).
Conclusion
The need to produce entirely novel n-3 LC-PUFA
sources for use in aquaculture is greater than ever with
the main finite marine resource, fish oil, being spread
thinner as the farmedfish industry grows tomeet demand
from an increasing global population. It is evident that
both microalgal and GM technologies possess the
capabilities to fulfil some, if not all, of the necessary
requirements to augment fish oil use in aquafeeds. It is
likely different sectors of the aquaculture industry will
favour one product over the other, most likely depending
upon production volumes, economics, consumer accept-
ability or regulatory issues. However, the availability of
such options should prevent further decline in n-3 LC-
PUFA levels in aquaculture and eventually lead to these
beneficial fatty acids being restored to previous levels to
ensure that farmed fish will remain a product of high
nutritional value.
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